A deep learning algorithm developed by Genentech and Roche researchers predicts a patient’s diabetic retinopathy progression using color fundus photographs acquired at a single visit, according to a study.
“Our deep learning pilot study shows the potential for a tool that is highly accurate in predicting diabetic retinopathy progression at an individual patient level in a single doctor visit. Such a tool could help inform the patient’s treatment strategy — earlier treatment depending on the risk for fast progression — in order to protect and preserve their vision,”
Uncategorized